ShownBio is a leading biotechnology company specializing in antibody specificity analysis . Since the company was founded in 2019, ShownBio independently constructed 6000+ plasma membrane proteins , established an automated, high-throughput detection platform, created a data visualization, traceable quality system, and created an internationally leading protein specific verification platform, which can provide "one-stop, integrated" protein non-specific screening services. The specificity verification platform includes 5 functional modules and 5 platforms, which provide systematic solutions for drug safety evaluation, provide theoretical basis for the study of virus mechanism, and provide scientific research ideas for ligand receptor orphaning. Provide design support for drug development and provide new possibilities for target discovery.

At present, ShownBio has three centers in Chongqing, Suzhou and Shenzhen, which are respectively responsible for technical R&D and project testing. It has spontaneously completed many cases of monoclonal antibody off-target research that have been marketed. It has established strategic cooperation relations with many head biomedical companies, and the test data reports provided have passed IND application and obtained implied license, thus solving a series of problems such as long time for sample inspection abroad and high communication cost, and assisting the R&D team to accelerate the R&D process and IND application. Reduce investment risk in R&D and clinical trials.